MENU
RIGL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Rigel Pharmaceuticals (RIGL) Earnings Date & Reports
Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases... Show more
Industry: #Biotechnology
A.I. Advisor
published Earnings
RIGL is expected to report earnings to rise 8.50% to 95 cents per share on November 10
Q3'26
Est.
$0.95
Q2'26
Beat
by $0.67
Q1'26
Beat
by $0.58
Q4'25
Beat
by $13.52
Q3'25
Beat
by $1.45
The last earnings report on August 04 showed earnings per share of 87 cents, beating the estimate of 20 cents. With 29.40K shares outstanding, the current market capitalization sits at 904.67M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information
General Information
a clinical-stage drug development company that discovers and develops novel, small-molecule drugs
Industry Biotechnology
Profile
Details
Industry
Biotechnology
Address
611 Gateway Boulevard
Phone
+1 650 624-1100
Employees
174
Web
https://www.rigel.com